» Articles » PMID: 29163976

Availability, Prices and Affordability of UN Commission's Lifesaving Medicines for Reproductive and Maternal Health in Uganda

Overview
Date 2017 Nov 23
PMID 29163976
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Uganda was one of seven countries in which the United Nations Commission on Life Saving Commodities (UNCoLSC) initiative was implemented starting from 2013. A nationwide survey was conducted in 2015 to determine availability, prices and affordability of essential UNCoLSC maternal and reproductive health (MRH) commodities.

Methods: The survey at health facilities in Uganda was conducted using an adapted version of the standardized methodology co-developed by World Health Organisation (WHO) and Health Action International (HAI). In this study, six maternal and reproductive health commodities, that were part of the UNCoLSC initiative, were studied in the public, private and mission health sectors. Median price ratios were calculated with Management Sciences for Health International Drug Price Indicator prices as reference. Maternal and reproductive health commodity stocks were reviewed from stock cards for their availability for a period of 6 months preceding the survey. Affordability was measured using wages of the lowest paid government worker.

Results: Overall none of the six maternal and reproductive commodities was found in the surveyed health facilities. Public sector had the highest availability (52%), followed by mission sector (36%) and then private sector had the least (30%). Stock outs ranged from 7 to 21 days in public sector; 2 to 23 days in private sector and 3 to 27 days in mission sector. During the survey, maternal health commodities were more available and had less number of stock out days than reproductive health commodities. Median price ratios (MPR) indicated that medicines and commodities were more expensive in Uganda compared to international reference prices. Furthermore, MRH medicines and commodities were more expensive and less affordable in private sector compared to mission sector.

Conclusion: Access to MRH commodities is inadequate in Uganda. Maternal health commodities were more available, cheaper and thus more affordable than reproductive health commodities in the current study. Efforts should be undertaken by the Ministry of Health and stakeholders to improve availability, prices and affordability of MRH commodities in Uganda to ensure that sustainable Development Goals are met.

Citing Articles

National-level key stakeholders' perspectives regarding intervention progression and emerging challenges within the national stillbirth reduction response in Uganda.

Ssegujja E, Andipatin M PLoS One. 2023; 18(4):e0285172.

PMID: 37115790 PMC: 10146451. DOI: 10.1371/journal.pone.0285172.


Inventory management performance for family planning, maternal and child health medicines in public health facilities of West Wollega zone, Ethiopia.

Kebede O, Tilahun G J Pharm Policy Pract. 2021; 14(1):20.

PMID: 33583427 PMC: 7883421. DOI: 10.1186/s40545-021-00304-z.


Evaluating Price and Availability of Essential Medicines in China: A Mixed Cross-Sectional and Longitudinal Study.

Yang C, Hu S, Ye D, Jiang M, Babar Z, Fang Y Front Pharmacol. 2020; 11:602421.

PMID: 33381042 PMC: 7768899. DOI: 10.3389/fphar.2020.602421.


Availability, price, and affordability of WHO priority maternal and child health medicine in public health facilities of Dessie, north-East Ethiopia.

Hailu A, Mohammed S BMC Med Inform Decis Mak. 2020; 20(1):221.

PMID: 32917201 PMC: 7488722. DOI: 10.1186/s12911-020-01247-2.


Access to sexual and reproductive health commodities in East and Southern Africa: a cross-country comparison of availability, affordability and stock-outs in Kenya, Tanzania, Uganda and Zambia.

Ooms G, Kibira D, Reed T, van den Ham H, Mantel-Teeuwisse A, Buckland-Merrett G BMC Public Health. 2020; 20(1):1053.

PMID: 32620159 PMC: 7333276. DOI: 10.1186/s12889-020-09155-w.


References
1.
Palafox B, Patouillard E, Tougher S, Goodman C, Hanson K, Kleinschmidt I . Prices and mark-ups on antimalarials: evidence from nationally representative studies in six malaria-endemic countries. Health Policy Plan. 2015; 31(2):148-60. PMC: 4748126. DOI: 10.1093/heapol/czv031. View

2.
Cameron A, Mantel-Teeuwisse A, Leufkens H, Laing R . Switching from originator brand medicines to generic equivalents in selected developing countries: how much could be saved?. Value Health. 2012; 15(5):664-73. DOI: 10.1016/j.jval.2012.04.004. View

3.
Jiang M, Zhou Z, Wu L, Shen Q, Lv B, Wang X . Medicine prices, availability, and affordability in the Shaanxi Province in China: implications for the future. Int J Clin Pharm. 2014; 37(1):12-7. DOI: 10.1007/s11096-014-0037-4. View

4.
Lawry L, Canteli C, Rabenzanahary T, Pramana W . A mixed methods assessment of barriers to maternal, newborn and child health in gogrial west, south Sudan. Reprod Health. 2017; 14(1):12. PMC: 5244729. DOI: 10.1186/s12978-016-0269-y. View

5.
Pronyk P, Nemser B, Maliqi B, Springstubb N, Sera D, Karimov R . The UN Commission on Life Saving Commodities 3 years on: global progress update and results of a multicountry assessment. Lancet Glob Health. 2016; 4(4):e276-86. DOI: 10.1016/S2214-109X(16)00046-2. View